As of 05/20/2025, Malin Corporation plc's market capitalization has reached $41.51 M. According to our data, Malin Corporation plc is the 30524th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 41.51 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | 0 |
| Shares Out | 4.33 M |
| EPS (ttm) | 0 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 05/27/2025 |
| Date | Market Cap | Change (%) |
|---|---|---|
| 05/20/2025 | €36.80 M | -77.35% |
| 12/31/2024 | €162.45 M | 91.96% |
| 12/29/2023 | €84.63 M | -65.71% |
| 12/30/2022 | €246.81 M | -15.58% |
| 12/30/2021 | €292.35 M | 55.19% |
| 12/29/2020 | €188.38 M |
Malin Corporation plc is a dynamic player in the life sciences sector, with operations spanning Ireland and the United States. Established in 2014 and headquartered in Dublin, Ireland, the company focuses on:
Malin Corporation is committed to fostering innovation and development in the life sciences field.
| Country or region | Ireland |
| Founded | 2014 |
| IPO Date | n/a |
| Employees | 2 |
| CEO | Fiona Dunlevy |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Address |
The Lennox Building Dublin, D02 FK02 Ireland |
| Website | https://www.malinplc.com |
Ireland
